DA-EPOCH-R
Dunleavy et al. ASH 2014
Prospective:
MYC
rearranged
(45 (14/31)%
BCL2
rearranged)
Oki et al. BJH 2014
Retrospective: MDACC DHL
DHL PFS 87%